At present, there is no discernible evidence of a cross-cutting or all-of-government strategy to increase the commercial dividends from the scientific capital we have accumulated in the biological sciences.
A 2017 report from Deloitte and BIOTECanada found 59 per cent of the companies said they were looking to government as their first source of future financing—the vast majority of such government funding comes through Innovation, Science, and Economic Development Canada, which is overseen by Navdeep Bains, pictured, as minister. The Hill Times photograph by Andrew Meade
TORONTO—Canada is rich in the scientific capital needed to make us a serious player in the transformative world of biotechnology.
People. Policy. Politics. This is an exclusive subscriber-only story.
But a Conservative source is decrying public criticism of Andrew Scheer's leadership, saying it will only create the kind of schisms that will set the party back and that former leader Stephen Harper worked to avoid.
'It is a weird irony that integration is being isolated this way,' says Anita Singh, while others say there’s an opportunity for the diversity, inclusion, and youth file to play a larger role in government.